Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Stop Loss Levels
Fixed Risk
Technical Levels
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹3,355.3 Cr | ₹2,667.1 Cr | ₹3,404.6 Cr | ₹3,558.7 Cr |
| Net Profit | ₹522.4 Cr | ₹320.1 Cr | ₹513.9 Cr | ₹560 Cr |
| EPS | ₹2.95 | — | ₹2.90 | ₹3.16 |
| Operating Profit | ₹810.4 Cr | ₹551.4 Cr | ₹811.4 Cr | ₹859.4 Cr |
Peer Comparison
Personal CarePeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| GODREJCP | Godrej Consumer Products Limited | ₹1,033.30 | +2.42% |
| COLPAL | Colgate Palmolive (India) Limited | ₹2,079.00 | +2.48% |
| PGHH | Procter & Gamble Hygiene and Health Care Limited | ₹8,993.50 | -0.34% |
| GILLETTE | Gillette India Limited | ₹7,726.00 | +0.75% |
| EMAMILTD | Emami Limited | ₹390.80 | +1.13% |
| HONASA | Honasa Consumer Limited | ₹413.65 | -0.96% |
| BAJAJCON | Bajaj Consumer Care Limited | ₹591.65 | +4.49% |
| CUPID | Cupid Limited | ₹159.97 | +3.09% |
| ANONDITA | Anondita Medicare Limited | ₹1,184.70 | +4.47% |
| MACOBSTECH | Macobs Technologies Limited | ₹212.00 | +0.00% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 07 Nov 2025 | Interim Dividend - Rs 2.75 Per Share | INTERIM_DIVIDEND |
| 18 Jul 2025 | Dividend - Rs 5.25 Per Share | DIVIDEND |
| 08 Nov 2024 | Interim Dividend - Rs 2.75 Per Share | INTERIM_DIVIDEND |
| 19 Jul 2024 | Annual General Meeting/Dividend - Rs 2.75 Per Share | AGM |
| 10 Nov 2023 | Interim Dividend - Rs 2.75 Per Share | INTERIM_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for DABUR
View AllDabur India says US FDA issues import alert for Silvassa plant drugs
Dabur India said the United States Food and Drug Administration (USFDA) issued Import Alert 66-40 for drugs made at part of its Silvassa facility after an inspection flagged data integrity and maintenance deficiencies.
Why US drug regulator has taken action against drugs imported from Dabur India
A live bird and bird droppings were found in the raw material warehouse, about 30 feet from packaging materials.
Dabur shares in focus after USFDA issues import alert for drugs made at Silvassa plant. Check details
Dabur India share price was trading on a flat note with a positive bias. The stock opened at ₹422.15 as against ₹422.20 apiece. It hit the day's high and low of ₹428.80 and ₹420.45.
